StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

GILDBullishAnalyst Target Updateanalyst
Medium materiality4/10

Gilead Sciences price target raised to $184 at BMO Capital

Oct 30, 2026, 7:29 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Moderately bullish analyst update, tempered by the lack of a stated rationale and the fact that targets are opinions.

AI summary

What happened, with direct paths to the underlying reporting

BMO Capital raised its GILD price target to $184 from a posted price of $165.61, implying about 11% upside to the target. The available facts do not provide the prior target or the analyst's rationale.

  • Price target: $184; posted price: $165.61.
  • The prior target and rationale are not provided.

Key facts

  1. 01

    Target: $184

  2. 02

    Posted price: $165.61

  3. 03

    Analyst firm: BMO Capital

  4. 04

    Analyst: Evan David Seigerman

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.